Skip to Content

Egrifta

In the US, Egrifta (tesamorelin systemic) is a member of the drug class growth hormones and is used to treat Lipodystrophy.

US matches:

Ingredient matches for Egrifta

Tesamorelin

Tesamorelin acetate (a derivative of Tesamorelin) is reported as an ingredient of Egrifta in the following countries:

  • United States

International Drug Name Search

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide